Vermillion's Q1 Revenues Drop 28 Percent; CEO Page to Leave Firm | GenomeWeb

NEW YORK (GenomeWeb News) – Vermillion reported after the close of the market on Tuesday that a drop in its product revenues led to a 28-percent decrease year over year in total revenues for the first quarter.

The company also announced that President and CEO Gail Page will be leaving the company by September and Vermillion has begun the process to find her successor.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.